GuiZhou SanLi Pharmaceutical Co., Ltd.SSE: 603439

Announcement on Expected Decrease in Performance for 2025

· Issued by GuiZhou SanLi Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE ·

Announcement on Expected Decrease in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

GuiZhou SanLi Pharmaceutical Co., Ltd. on 6ix

Earlier from GuiZhou SanLi Pharmaceutical

Later from GuiZhou SanLi Pharmaceutical

All GuiZhou SanLi Pharmaceutical news releases